Fierce Biotech

Fierce Biotech Fundraising Tracker ’26: Immutrin’s $87M series A; Crossbow targets $77M

Published

on

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version